Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€86.85
08.07.21
€115.00
08.07.22
13.32%
08.07.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
gerihouse 
08.07.21 80%
sell
Abivax S.A.

Start price
Target price
Perf. (%)
€30.50
28.06.21
€25.00
28.06.22
-16.39%
01.12.21

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Snowman 
28.06.21 50%
sell
Valneva SE

Start price
Target price
Perf. (%)
€10.89
17.06.21
€8.00
17.06.22
3.21%
20.07.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
melinda 
17.06.21 50%
buy
Spineway

Start price
Target price
Perf. (%)
€68.00
15.06.21
-
15.06.22
-52.94%
16.02.22

Could be very worthwhile Investment >20% year
Market Leader or Top 3
Heyer1977 
15.06.21 50%
buy
Advicenne

Start price
Target price
Perf. (%)
€8.74
30.05.21
€10.00
30.05.22
-10.98%
31.08.21

Could be worthwhile Investment >10% per year
melinda 
30.05.21 50%
sell
Virbac S.A.

Start price
Target price
Perf. (%)
€275.00
28.04.21
€270.00
28.04.22
43.82%
25.10.21

Could be worthwhile Investment >10% per year
melinda 
28.04.21 40%
sell
Boiron S.A.

Start price
Target price
Perf. (%)
€38.55
13.04.21
€36.00
13.04.22
-1.30%
26.11.21

Could be worthwhile Investment >10% per year
melinda 
13.04.21 50%
buy
bioMerieux S.A.

Start price
Target price
Perf. (%)
€111.90
12.04.21
€120.00
12.04.22
-3.84%
07.11.21

Could be worthwhile Investment >10% per year
melinda 
12.04.21 50%
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€22.15
12.04.21
€28.35
12.04.22
-51.96%
24.12.21

Could be worthwhile Investment >10% per year
melinda 
12.04.21 50%
buy
Pixium Vision S.A.

Start price
Target price
Perf. (%)
€1.03
17.02.21
€3.00
17.02.22
-24.32%
25.12.21

Could be very worthwhile Investment >20% year
Leading role in innovation
Future proof or reliable business model
DaxiDriver 
17.02.21 60%
buy
Advicenne

Start price
Target price
Perf. (%)
€13.60
14.02.21
€14.00
14.02.22
-35.74%
30.05.21

Could be worthwhile Investment >10% per year
melinda 
14.02.21 50%
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.86
25.01.21
€1.00
25.01.22
-80.01%
24.01.22

Could be worthwhile Investment >10% per year
melinda 
25.01.21 50%
buy
Biosynex

Start price
Target price
Perf. (%)
€21.20
25.01.21
€26.00
25.01.22
-26.13%
20.10.21

Could be worthwhile Investment >10% per year
melinda 
25.01.21 50%
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€3.67
21.01.21
€10.00
21.01.22
-28.61%
22.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
21.01.21 50%
sell
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€8.16
15.01.21
-
15.01.22
-63.58%
16.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
shadow 
15.01.21 0%
buy
Adocia

Start price
Target price
Perf. (%)
€7.54
16.11.20
€10.00
16.11.21
18.04%
17.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
yester 
16.11.20 50%
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.10
15.11.20
€5.50
15.11.21
7.86%
16.11.21

Could be worthwhile Investment >10% per year
melinda 
15.11.20 50%
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€3.45
03.11.20
-
04.11.21
136.51%
15.01.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
shadow 
03.11.20 50%
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€3.53
03.11.20
€10.50
04.11.21
51.47%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
03.11.20 50%
sell
Novacyt S.A.

Start price
Target price
Perf. (%)
€10.10
19.10.20
€4.00
30.10.20
14.26%
30.10.20

Probably not worthwhile Investment
marge 
19.10.20 50%
sell
Novacyt S.A.

Start price
Target price
Perf. (%)
€10.10
19.10.20
-
04.11.21
-72.31%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
shadow 
19.10.20 50%
buy
Bastide Le Confort

Start price
Target price
Perf. (%)
€45.70
11.10.20
€48.00
04.11.21
-7.11%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
11.10.20 50%
buy
Onxeo S.A.

Start price
Target price
Perf. (%)
€0.64
11.10.20
€0.80
04.11.21
-23.46%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
11.10.20 50%
buy
Valbiotis

Start price
Target price
Perf. (%)
€8.00
19.07.20
€7.50
04.11.21
-11.88%
26.09.21

Could be worthwhile Investment >10% per year
melinda 
19.07.20 50%
buy
Ipsen S.A.

Start price
Target price
Perf. (%)
€81.00
13.07.20
€95.00
04.11.21
12.32%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
13.07.20 50%